Skip to main content
TOPICS
Videos
Provider
Payer
Pharma
Consumer
Investor
RESOURCES
Events
Jobs
Learning Center
Webinars
White Papers
REGIONS
ANZ
ASIA
EMEA
Global Edition
MORE
About
Advertise
Contact
Privacy Policy
ANZ
ASIA
EMEA
Global Edition
Winterlight Labs
Pear Therapeutics acquires new VR therapeutics, licenses CBT, vocal biomarker tech with flurry of new deals
By
Dave Muoio
|
05:05 pm |
January 07, 2020
New agreements with five different tech companies and research organizations aim to expand and flesh out the digital therapeutics maker's product pipeline.